107 related articles for article (PubMed ID: 33544997)
1. Genetic variants and risk of thyroid cancer among Iranian patients.
Jamshidi M; Farnoosh G; Mohammadi Pour S; Rafiee F; Saeedi Boroujeni A; Mahmoudian-Sani MR
Horm Mol Biol Clin Investig; 2021 Feb; 42(2):223-234. PubMed ID: 33544997
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of differentiated thyroid carcinoma with combined effects of homologous recombination repair gene polymorphisms in an Iranian population.
Fayaz S; Karimmirza M; Tanhaei S; Fathi M; Torbati PM; Fard-Esfahani P
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6727-31. PubMed ID: 24377596
[TBL] [Abstract][Full Text] [Related]
3. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
[TBL] [Abstract][Full Text] [Related]
4. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K
J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features.
Heidari Z; Mohammadpour-Gharehbagh A; Eskandari M; Harati-Sadegh M; Salimi S
J Cell Biochem; 2019 May; 120(5):8640-8647. PubMed ID: 30552691
[TBL] [Abstract][Full Text] [Related]
6. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk.
Bastos HN; Antão MR; Silva SN; Azevedo AP; Manita I; Teixeira V; Pina JE; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Thyroid; 2009 Oct; 19(10):1067-75. PubMed ID: 19772428
[TBL] [Abstract][Full Text] [Related]
8. The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population.
Rahimi M; Fayaz S; Fard-Esfahani A; Modarressi MH; Akrami SM; Fard-Esfahani P
Iran Biomed J; 2012; 16(4):218-22. PubMed ID: 23183621
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
10. Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Babaei E; Montazeri V; Fakhrjoo A; Sedaei A; Azarfam P; Nemati M
Pathol Oncol Res; 2015 Apr; 21(2):449-54. PubMed ID: 25410025
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
12. XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.
Pérez LO; Crivaro A; Barbisan G; Poleri L; Golijow CD
Pathol Oncol Res; 2013 Jul; 19(3):553-8. PubMed ID: 23539294
[TBL] [Abstract][Full Text] [Related]
13. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
[TBL] [Abstract][Full Text] [Related]
15. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
16. An increased risk of differentiated thyroid carcinoma in Iran with the 677C→T homozygous polymorphism in the MTHFR Gene.
Fard-Esfahani P; Fard-Esfahani A; Saidi P; Fayaz S; Mohabati R; Majdi M
Cancer Epidemiol; 2011 Feb; 35(1):56-8. PubMed ID: 21050834
[TBL] [Abstract][Full Text] [Related]
17. Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer.
Sarwar R; Mahjabeen I; Bashir K; Saeed S; Kayani MA
Cell Physiol Biochem; 2017; 42(1):22-33. PubMed ID: 28490032
[TBL] [Abstract][Full Text] [Related]
18. Association of MTHFR 677C>T, 1298A>C and MTR 2756A>G Polymorphisms with Risk of Retinoblastoma.
Gohari M; Dastgheib S. A.; Jafari-Nedooshan J; Akbarian-Bafghi M. J.; Morovati-Sharifabad M; Mirjalili S. R.; Neamatzadeh H
Klin Onkol; 2019; 32(5):375-379. PubMed ID: 31610671
[TBL] [Abstract][Full Text] [Related]
19. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
[TBL] [Abstract][Full Text] [Related]
20. Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).
Khan MS; Pandith AA; Ul Hussain M; Iqbal M; Khan NP; Wani KA; Masoodi SR; Mudassar S
Tumour Biol; 2013 Feb; 34(1):521-9. PubMed ID: 23150177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
